These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4368790)

  • 1. Immunofluorescence and elution studies in tetraparental NZB forms and is formed from CFW chimaeras and graft-versus-host diseased NZB.
    Barnes RD; Holliday J; Tuffrey M
    Immunology; 1974 Jun; 26(6):1195-206. PubMed ID: 4368790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal lesions in tetraparental NZB formed and is formed from CFW mouse chimaeras simulated in NZB by injection of CFW spleen cells.
    Tuffrey M; Holliday J; Barnes RD
    J Pathol; 1974 May; 113(1):61-7. PubMed ID: 4607012
    [No Abstract]   [Full Text] [Related]  

  • 3. The disease of the NZB mouse. I. Examination of ovum fusion derived tetraparental NZB:CFW chimaeras.
    Barnes RD; Tuffrey M; Kingman J; Thornton C; Turner MW
    Clin Exp Immunol; 1972 Aug; 11(4):605-28. PubMed ID: 4404414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease in the progeny of ovum fusion derived tetraparental NZB--CFW chimaeras.
    Tuffrey M; Kingman J; Barnes RD
    J Pathol; 1973 Nov; 111(3):213-9. PubMed ID: 4543379
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced levels of serum haemolytic complement and renal lesions in ovum-fusion-derived tetraparental mouse chimaeras.
    Barnes D; Tuffrey M; Graham CF; Holliday J; Thorton C
    Scand J Immunol; 1974; 3(6):789-96. PubMed ID: 4617295
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance in ovum fusion derived tetraparental mouse chimaeras.
    Barnes RD; Tuffrey M
    Adv Exp Med Biol; 1973; 29(0):427-34. PubMed ID: 4153153
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft-versus-host potential of long-term H-2-tolerant parabiosed mice.
    Drell DW; Wegmann TG
    Transplant Proc; 1977 Mar; 9(1):927-30. PubMed ID: 17205
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance of histoincompatible marrow grafts.
    Click RE
    Transplant Proc; 1979 Mar; 11(1):490-3. PubMed ID: 377683
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in Ia expression in mouse kidney during acute graft-vs-host disease.
    Wadgymar A; Urmson J; Baumal R; Halloran PF
    J Immunol; 1984 Apr; 132(4):1826-32. PubMed ID: 6366052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-way occurrence of graft-versus-host disease in bone marrow chimaeras between congenic MRL mice.
    Fujiwara M; Kariyone A
    Immunology; 1984 Oct; 53(2):251-6. PubMed ID: 6237981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis.
    Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C
    Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of host-versus-graft and graft-versus-host reactions on the immune response of mice to sheep red blood cells.
    Zaleski M
    Folia Biol (Praha); 1971; 17(2):111-22. PubMed ID: 4396932
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice.
    Sandberg JS; Owens AH; Santos GW
    J Natl Cancer Inst; 1971 Jan; 46(1):151-60. PubMed ID: 4395991
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatitis induced by the graft-versus-host reaction.
    Walters MN
    J Pathol Bacteriol; 1966 Jan; 91(1):65-9. PubMed ID: 5941402
    [No Abstract]   [Full Text] [Related]  

  • 16. The suppression of graft-versus-host disease in mice by endotoxin-treated adherent spleen cells.
    Thomson PD; Jutila JW
    J Reticuloendothel Soc; 1974 Dec; 16(6):327-9. PubMed ID: 4616077
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW; Owens AH
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract]   [Full Text] [Related]  

  • 19. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The host response in graft versus host disease. III. The in vitro induction of regulatory cells in chronic murine graft versus host disease.
    Mann RA; Singh AB; Jetzt AE; Singh M
    Cell Immunol; 1995 Aug; 164(1):1-10. PubMed ID: 7634339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.